Opérations
Qui sommes-nous ?
L’entreprise
Equipe
Nos bureaux
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Conseil en matière de dette
Equity Research
Levées de Fonds – Séries A, B, C ….
Stratégie et préparation de l’introduction en bourse
Industries
Services aux Entreprises
Consumer / Retail / E-commerce
Technologie industrielle
Life science et Santé
Software / TMT
Career
Evénements
Insights
News
Company News
Deal News
Carlsquare in the Media
Newsletter
Contactez-nous
Newsletter
FR
INT
DA
DE
SV
US
Main menu button
Equipe
Opérations
Contact
Equipe
Opérations
Contact
Actualités
Tout
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
Tout
Company News
Deal News
Equity Research
Events
Insights
Macro and markets
Media
25 Fév 2025
Equity research Teneo AI, Q4 2024: Teneo continues to deliver above expectations
Equity Research
Teneo AI
15 Jan 2025
Equity research Teneo AI: Preliminary figures above expectations
Equity Research
Teneo AI
25 Oct 2024
Equity research Teneo AI, Q3 2024: Excellent growth driven by increased volumes
Equity Research
Teneo AI
22 Août 2024
Equity research, Teneo AI: Strong growth outlook remains after a solid Q2
Equity Research
Teneo AI
21 Août 2024
Equity research Teneo AI: A solid Q2 report with an impressive API call growth
Equity Research
Teneo AI
13 Août 2024
Equity research Artificial Solutions: Expecting continued steady growth in Q2 2024
Equity Research
Teneo AI
20 Juin 2024
Equity research Artificial Solutions: Improved financial strength and proven investor interest
Equity Research
Teneo AI
10 Juin 2024
Equity research, Artificial Solutions: Enabling contact centre excellence through AI
Equity Research
Teneo AI
29 Avr 2024
Equity research Artificial Solutions: Outstanding NRR signals high value added and effectiveness
Equity Research
Teneo AI